Can an mRNA injection slow aging? new study begins

NCT ID NCT07544420

First seen Apr 25, 2026 · Last updated May 07, 2026 · Updated 2 times

Summary

This early-stage study tests a new mRNA treatment called AKL003 in healthy adults aged 50 to 90. The goal is to see if it is safe and can increase levels of a protein linked to aging. Participants will receive two injections and be monitored for side effects and protein levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • GARM

    Roatán, Bay Islands, 34101, Honduras

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.